Kronos Bio Announces Participation in the Jefferies Virtual Healthcare Conference

SAN MATEO, Calif. & CAMBRIDGE, Mass.--()--Kronos Bio, Inc., dedicated to drugging transcriptional regulatory networks in cancer, today announced that Norbert Bischofberger, Ph.D., President and Chief Executive Officer will present at the Jefferies Virtual Healthcare Conference taking place June 2-4, 2020.

Presentation Date: Wednesday, June 3, 2020
Presentation Time: 4:30 PM ET

A webcast will be made available on the Company's website at www.kronosbio.com in the News and Events section. Following the live audio webcast, a replay will be available on the Company's website for approximately 30 days.

About Kronos Bio

Kronos Bio, Inc. is dedicated to drugging transcriptional regulatory networks in cancer. We leverage deep capabilities in computational biology, chemical biology and clinical translational expertise in order to map transcriptional regulatory networks in cancer, identify vulnerabilities and screen for small molecule modulators.

For more information, please visit www.kronosbio.com or follow the company on LinkedIn.

Contacts

Kronos Bio Contact:
Christopher Wilfong
Chief Operating Officer
media@kronosbio.com

Contacts

Kronos Bio Contact:
Christopher Wilfong
Chief Operating Officer
media@kronosbio.com